Onpharno Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 16-12-2024
- Revenue -56.38%
(FY 2020)
- Profit 313.47%
(FY 2020)
- Ebitda 166.87%
(FY 2020)
- Net Worth 54.49%
(FY 2020)
- Total Assets 13.37%
(FY 2020)
About Onpharno Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Rekha Poddar and Mayur Poddar serve as directors at the Company.
- CIN/LLPIN
U33111GJ2015PTC082238
- Company No.
082238
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Onpharno Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mayur Poddar  | Director | 12-Feb-2015 | Current |
| Rekha Poddar | Director | 16-Mar-2018 | Current |
Financial Performance of Onpharno Lifesciences.
Onpharno Lifesciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 56.38% decrease. The company also saw a substantial improvement in profitability, with a 313.47% increase in profit. The company's net worth Soared by an impressive increase of 54.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Onpharno Lifesciences?
In 2017, Onpharno Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Creation Date: 25 Apr 2022 | ₹1.00 M | Open |
How Many Employees Work at Onpharno Lifesciences?
Unlock and access historical data on people associated with Onpharno Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Onpharno Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onpharno Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
